In our immunohistochemical analyses conducted on tissues from CRC patients, high levels of biglycan expression were detected in the stroma around the CRC tissue, which is supportive of the critical role that increased biglycan expression plays in the ECM contributing to tumor progression. This evidence concerns the gene BGN and colorectal carcinoma.